Mindray and United Imaging: Chinese Medical Devices Capture 20% of Global Imaging Market
Chinese medical imaging companies led by Mindray and United Imaging have captured approximately 20% of the global medical imaging market, offering MRI, CT, and ultrasound systems at 30-50% below the Siemens-GE-Philips oligopoly.
- Market share gains and product range
- Price disruption and total cost of ownership
- Technology advancement and clinical validation
- Market access and regulatory pathways
Market share gains and product range#
Chinese medical imaging companies have collectively captured approximately 20% of the global market by value in 2025, up from 8% five years earlier. Mindray leads with a comprehensive portfolio spanning patient monitoring, ultrasound, and laboratory diagnostics, generating over $5 billion in annual revenue with 40% from international markets. United Imaging has focused on premium imaging modalities including MRI, CT, and PET-CT systems that directly challenge the established oligopoly. The pace of market share gain has accelerated as product quality improvements close the specification gap with Western incumbents.
Price disruption and total cost of ownership#
A United Imaging 3T MRI system costs approximately $1.5-2 million compared to $3-4 million for equivalent Siemens or GE platforms, a price difference that significantly changes hospital imaging department economics. Similar price advantages of 30-50% apply across CT scanners, ultrasound systems, and patient monitoring equipment. The total cost of ownership advantage extends to service contracts, which Chinese manufacturers price 20-40% below Western incumbents. For healthcare systems facing budget constraints, Chinese imaging equipment offers the possibility of expanding diagnostic capacity at dramatically lower capital investment.
Technology advancement and clinical validation#
United Imaging uMR Jupiter 5T MRI system, the world first commercially available 5-Tesla whole-body MRI, demonstrated that Chinese manufacturers can lead in clinical imaging technology. Mindray AI-powered ultrasound platforms offer automated measurement and diagnostic assistance features that match or exceed Western competitors in independent evaluations. Chinese manufacturers collectively file more medical imaging patents annually than any single Western competitor. Clinical validation studies published in peer-reviewed journals are accumulating, gradually overcoming initial scepticism.
Data-backed guides on AI, eCommerce, and SME strategy — straight to your inbox.
Market access and regulatory pathways#
Chinese medical imaging companies have obtained FDA clearance and EU CE marking for an expanding range of products, enabling sales in the most regulated healthcare markets. Mindray products are installed in over 190 countries, with established distribution networks in Europe, Latin America, and Africa. The regulatory pathway is demanding but well-understood, with Chinese manufacturers investing in clinical trials and quality management systems meeting international standards. Some US healthcare institutions have begun evaluating Chinese imaging equipment, though procurement decisions in major Western hospital systems remain influenced by existing service relationships.
People also ask
Are Chinese MRI machines as good as Siemens or GE?
Chinese manufacturers like United Imaging have achieved comparable clinical performance in many applications, with the world first commercially available 5-Tesla whole-body MRI system. Price advantages of 30-50% make them increasingly compelling for budget-conscious healthcare systems.
What is Mindray market share?
Mindray is the world largest Chinese medical device manufacturer with over $5 billion in annual revenue and approximately 40% from international markets, holding significant global shares in patient monitoring, ultrasound, and laboratory diagnostics.
Can hospitals buy Chinese medical imaging equipment?
Yes, major Chinese medical imaging companies have obtained FDA clearance and EU CE marking. Mindray equipment is installed in over 190 countries, though Western hospital procurement still favours established vendors for premium applications.
Our team combines expertise in data analytics, SME strategy, and AI tools to produce practical guides that help founders and operators make better business decisions.
Turn trade intelligence into action
Upload your import/export data and let AskBiz analyse your China trade exposure, margins, and opportunities.
Start free — no credit card required →